http://www.acc.org/Feed?clinicalTopicID=a4c26654-d6e7-4dae-8f05-a936b77d628e Clinical Topic Feed: Mitral Regurgitation en /Latest-in-Cardiology/Journal-Scans/2026/07/07/13/29/Novel-TEER-System For high-risk patients with primary mitral valve regurgitation (MR), the novel Neonova transcatheter edge-to-edge repair (TEER) system was safe and effective, with a high rate of event-free survival and sustained clinical and echocardiographic improvements through two years, according to a prospective study published June 29 in JACC: Asia. 1783537920000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1782907740000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/16/16/01/eagles-eye-view-17jun2026 In this week’s View, Dr. Eagle highlights a study showing race and sex disparities in M-TEER outcomes, with Black patients presenting with more advanced disease, lower success, and higher heart failure readmissions than White patients, and women having lower success rates than men. 1781701440000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/08/17/44/Racial-and-Sex-Disparities-in-M-TEER-Outcomes Black patients undergoing mitral transcatheter edge-to-edge repair (M-TEER) were more likely to present with more advanced disease, had lower procedural success and higher heart failure (HF) readmission rates vs. White patients, and female patients had lower procedural success rates vs. male patients... 1780940640000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/01/01/Editors-Corner This month's cover story offers a practical, concise review of contemporary care for patients with tricuspid regurgitation (TR). It synthesizes key lessons from clinical trials that now guide decision-making for direct tricuspid valve interventions. 1780316400000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/27/15/57/eagles-eye-view-27may2026 In this week’s View, Dr. Eagle examines recent research into maintaining weight loss with tirzepatide. He then offers insights into the new dyslipidemia guidelines, including addressing reproductive and hormone risk factors in cardiovascular risk assessment. 1779898740000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/05/18/18/10/JACC-Journals-Science-From-EuroPCR-2026 Findings from four late-breaking clinical trials presented at EuroPCR 2026 in Paris, France, were simultaneously published in JACC: Cardiovascular Interventions. Together they lend new insights into residual tricuspid regurgitation (TR) after tricuspid valve transcatheter edge-to-edge repair (T-TEER), the safety of transfemoral (TF) transcatheter mitral valve replacement (TMVR), the novel BATMAN-TMVR technique, and the effect of implant depth on TAVR outcomes. 1779371700000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/05/18/18/10/PRAISE-MR In patients with atrial functional mitral regurgitation (AFMR) and heart failure with reduced ejection fraction (HFpEF), sacubitril/valsartan was associated with improvements in exercise hemodynamics and peak oxygen consumption (VO2), along with attenuation of an exercised-induced increase in AFMR... 1779370200000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/01/01/JACC-in-a-Flash Featured topics and Editors' Picks from all of ACC's JACC Journals. 1777637400000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/04/27/14/03/Is-Same-Day-Discharge-Safe-After-M-TEER Same-day discharge (SDD) following mitral transcatheter edge-to-edge repair (M-TEER) was found to be uncommon, but compared with next-day discharge (NDD) it was associated with a similar risk of 90-day readmission and lower costs for the index hospitalization, according to research presented April 25... 1777386420000 Articles and Stories